myMPNteam

How does the DNMT3A mutation affect the progression and symptoms of essential thrombocythemia (ET)?

The search results provided don't contain specific information about DNMT3A mutations in essential thrombocythemia. The available information focuses on the most common genetic mutations associated with ET, which include:

- Show Full Answer

How does the DNMT3A mutation affect the progression and symptoms of essential thrombocythemia (ET)?

The search results provided don't contain specific information about DNMT3A mutations in essential thrombocythemia. The available information focuses on the most common genetic mutations associated with ET, which include:

- JAK2V617F mutation (found in most ET cases)
- CALR (calreticulin) gene mutations
- MPL (myeloproliferative leukemia) gene mutations

Some cases don't have any of these three mutations and are called triple-negative ET.

While DNMT3A mutations can occur in myeloproliferative neoplasms, the specific impact on ET progression and symptoms isn't covered in the current information. It would be best to discuss DNMT3A mutation findings with your hematologist, as they can explain how this particular mutation might affect your individual case and treatment approach.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Essential Thrombocythemia: Causes, Symptoms, and Treatments